Shuddering Attacks in an Infant Treated with Atenolol for Infantile Hemangioma: A Previously Unreported Adverse Effect
Complicated infantile hemangiomas require treatment, often with oral beta-blockers. Atenolol, a selective beta-blocker with rare neurological side effects, is considered a safer alternative to propranolol. This article reports a case of shuddering attacks, occurring during atenolol therapy, highlighting a previously unreported potential medication-related adverse effect.
Authors
- Omer Bar‐Yosef (ORCID: https://orcid.org/0000-0002-7052-5238)
- Shoshana Greenberger (ORCID: https://orcid.org/0000-0001-8308-2790)
- Yaara Yerushalmi
Institutions
- Tel Aviv University (IL)
- Sheba Medical Center (IL)
- Edmond and Lily Safra Children's Hospital (IL)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2026-06-25
- DOI
- https://doi.org/10.1093/ced/llag278
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00